Skip to main content
Neoplasia (New York, N.Y.) logoLink to Neoplasia (New York, N.Y.)
. 2009 Feb;11(2):1.

Erratum

PMCID: PMC2659732

(1) In this article published in the January 2009 issue of Neoplasia, the HhAntag691 was obtained from Genentech, San Francisco, CA, and is not structurally equivalent to GDC-0449 as suggested in this contribution.

References

  • 1.Zhang Y, Laterra J, Pomper MG. The hedgehog pathway inhibitor HhAntag691 is a potential inhibitor of ABCG2/BCRP and ABCB1/Pgp. Neoplasia. 2009;11:96–101. doi: 10.1593/neo.81264. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neoplasia (New York, N.Y.) are provided here courtesy of Neoplasia Press

RESOURCES